Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Capture-Recapture as a Potentially Useful Procedure for Assessing Prevalence of Multiple Sclerosis: Methodologic Exercise Using Portuguese Data.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
Assessing walking disability in multiple sclerosis.
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
Anti-integrin therapy for multiple sclerosis.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Gray matter is targeted in first-attack multiple sclerosis.
A biopsychosocial model of resilience for multiple sclerosis.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.

Pages